BASL logo

November 29th and 30th, 2024

BASL Winter Meeting and Liver Course

Location

Van Diepenbeeckstraat 12, 2018 Antwerpen

Inrit parking
Lamorinièrestraat 53
2018 Antwerpen
 

Friday 29 November 2024

Liver Course program: Alcohol related liver disease

8.30-9.00 Registration

09.00-10.15 Session 1: HEPATOLOGY UPDATE
Moderators: Thomas Vanwolleghem and Eric Trepo (TBC)

  1. MASH CPG: update: Elisabetta Bugianesi (University of Torino, Italy)
  2. Benign Tumours: Jean Charles Nault (Paris Descartes Universite, France)


10.15-10.45 COFFEE BREAK


10.45-12.00 Session 2: NON-INTERACTIVE DISCUSSION OF CLINICAL CASES
Moderators: Filip Janssens and Marie de Vos (TBC)


12.00-12.15 Presentations of BASL YOUNG INVESTIGATORS AWARDS LAUREATES 2024 and short presentation by 2023 Laureates


12.15-12.30 BASL awards for the best clinical and basic publications 2023
(Thomas Vanwolleghem)


12.30-13.30 LUNCH


13.30-15.00 Session 3: Alcohol-related liver disease (first part)
Moderators: Pierre Deltenre and Anja Geerts (TBC)

  1. Epidemiology and Diagnosis – Peter Stärkel (UCLouvain, Belgium)
  2. Alcohol use disorder – Philippe De Timary (UCLouvain, Belgium)
  3. Indications for liver transplantation in alcoholic hepatitis and alcohol-related liver disease and impact of alcohol relapse after transplantation – Philippe Mathurin (University Hospital Lille, France)


15.00-15.15 COFFEE BREAK


15.15-16.45 Session 4: Alcohol-related liver disease (second part)
Moderators: Wim Laleman and Sergio Negrin Dastis (TBC)

  1. MetALD: How to deal with it? – A Krag (Odense University Hospital, Denmark)
  2. Home monitoring for patients with decompensated cirrhosis – Raj Mookerjee (University College London, UK)
  3. Non-oncological palliative care in hepatology – Nathalie Décosterd (Bern, Switzerland)

 

16.45-17.00 Conclusions and farewell

Saturday 30 November 2024

Liver Course program: Viral hepatitis

8.30-9.00 Registration


9.00-10.45  Session 1: Viral Hepatitis B/D: current and future treatment, special populations
Moderators:
Marie Coessens and Pierre Deltenre

  • Hepatitis B & D: clinical implications, current treatment
    Thomas Vanwolleghem (University of Antwerp)
  • Hepatitis B: Immunology and future therapeutics
    Patrick Kennedy (University of London)
  • Viral hepatitis in immunocompromised patients and pregnancy
    Thomas Sersté (CHU Saint-Pierre/CUB, Brussels)


10.45-11.15 COFFEE  BREAK
 

11.15-13.00  Session 1: Other viral hepatitis infections
Moderators: Sander Lefere and Wim  Verlinden

  • Hepatitis C
    Sergio Negrin-Dastis (Grand Hopital de Charleroi/UCL Saint Luc, Brussels)
  • Hepatitis A en E: translational insights
    Sven Pischke (University of Hamburg)
  • Clinical importance of non-A-to-E hepatitis (including adenovirus hepatitis in children)
    Speaker TBC

 

13.00   Conclusion and farewell (Sander Lefere, yBASL)

Other BASL activities

The next BASL steering committee will be elected by all BASL members.

BASL steering committee 2025-2028 elections

BASL - Belgian Association for the Study of the Liver
Leuvensesteenweg 643
1930 Nossegem
basl(at)basl.be